Skip to content

NIH Websites Are Changing

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
299 items
Dr. Emily Chew of the National Eye Institute examines a patient’s eyes. Photo credit: National Eye Institute.

Eye Study Underscores the Long-lasting Benefits of Controlling Diabetes

People with type 2 diabetes who intensively controlled their blood sugar level were found to have cut their risk of diabetic retinopathy in half.
African American male patient gets eye exam from doctor

Visual impairment, blindness cases in U.S. expected to double by 2050

The number of people with visual impairment or blindness in the United States is expected to double to more than 8 million by 2050, according to projections.
Grantee News

USC Roski Eye Institute researchers publish largest eye study of age-related macular degeneration in Latino population that analyzes impact on quality of life

The University of Southern California (USC) Roski Eye Institute researchers and clinicians published results of the largest population-based study of adult Latinos and age-related macular degeneration (AMD).
Patient undergoes and eye exam. Courtesy National Eye Institute.

Age-related macular degeneration before and after the era of anti-VEGF drugs

In a study of nearly 650 people with the eye disease age-related macular degeneration (AMD), half still had vision 20/40 or better after five years of treatment with anti-VEGF drugs that are injected into the eye.
Grantee News

USC Roski Eye Institute Researchers Publish Largest Eye Study Among Chinese Americans Identifying More Effective Ways to Prevent and Treat Blinding Eye Diseases for This Racial Group

Researchers and clinicians at the University of Southern California Roski Eye Institute have published results of the NEI-funded “Chinese American Eye Study” in JAMA Ophthalmology.
Patient undergoes and eye exam. Courtesy National Eye Institute.

Eylea Outperforms Avastin for Diabetic Macular Edema with Moderate or Worse Vision Loss

A two-year clinical trial that compared three drugs for diabetic macular edema (DME) found that gains in vision were greater for participants receiving the drug Eylea (aflibercept) than for those receiving Avastin (bevacizumab).
Moderate hyperopia, if not treated, may affect reading ability and grade school readiness among preschoolers. Credit: Joe Balintfy, NEI.

Uncorrected Farsightedness Linked to Literacy Deficits in Preschoolers

A study funded by the National Eye Institute (NEI), part of the National Institutes of Health, has shown that uncorrected farsightedness (hyperopia) in preschool children is associated with significantly worse performance on a test of early literacy.
NEI image using a slit lamp

New Treatment Options, Better Hope of Preventing Vision Loss from Diabetes

This National Diabetes Month, there is some good news for people with eye complications from diabetes.
Animation of abnormal blood vessels bleeding into the center of the eye due to proliferative diabetic retinopathy. Photo credit: National Eye Institute. Watch video.

Lucentis Effective for Proliferative Diabetic Retinopathy

A clinical trial funded by the National Institutes of Health has found that the drug ranibizumab (Lucentis) is highly effective in treating proliferative diabetic retinopathy.
Dr. Rachel Bishop and Dr. Allen Eghrari, from the Johns Hopkins University Wilmer Eye Institute, shown here with the advanced imaging technologies being used for the PREVAIL III study in Monrovia, Liberia.

NEI Team in Liberia Investigates Ocular Effects Among Ebola Survivors

Following the 2014 Ebola outbreak in West Africa that took the lives of more than 11,200 people in the region, the National Eye Institute, part of the National Institutes of Health, has deployed a team of clinicians and technical experts to Monrovia...